The aminoglycosides family of antibiotics are widely used as a prophylactic measure against bacterial contamination in animal vaccine production.
INTRODUCTION
Since the discovery of penicillin in 1928 many antibiotics including aminoglycosides, blactams, fluoroquinolones, and others have been applied clinically for the treatment of many growing number of multidrug-resistant strains of bacteria. Aminoglycosides in particular are being examined to find new compounds or derivatives that might overcome the existing resistant pathogens and prevent or slow the development of novel resistant pathogens.
Aminoglycosides were first established as antibiotics in the 1940s with the discovery of streptomycin and are still widely used worldwide. Aminoglycosides have enjoyed widespread application as chemotherapeutic agents in the treatments of many types of bacterial infections, including both Grampositive and Gram-negative pathogens (Davies and Wright 1997) . The antibacterial mechanism of action of aminoglycosides has been well characterized, and it was discovered in the late 1980s that aminoglycosides' molecular target is the 16S rRNA subunit of the 30S bacterial ribosome (Moazed and Noller 1987) .
Although alternative modes of binding have been seen with various aminoglycoside derivatives (Kondo et al., 2007) , the general interactions of aminoglycosides with three unpaired adenine residues in the decoding loop displaces non-complementary adenines and locks them into a so-called "flipped-out" orientation similar to that ob-served during mRNA decoding (Pfister et Kondo et al., 2006) . These interactions reduce the fidelity of normal translational processes by reducing the ability of the ribosome to discriminate between the proper mRNA-tRNA complexes, this leads to the accumulation of truncated or nonfunctional proteins in cells, and eventually to cell death. For a thorough structure-based analysis of the interactions of aminoglycosides with the decoding A-site see the recent review by (Francois et al 2005) .
The structurally related aminoglycosides neomycin, paromomycin and gentamycin possess 4,5-substituted and 4,6-substituted 2deoxystreptamine cores.
These compounds exert multiple effects on protein synthesis: they cause mRNA miscoding (Davies et al., 1965 (Davies et al., , 1966 , inhibit mRNA and tRNA translocation (Ingrid Kuhlmann 1996) mentioned that, In order to yield reproducable results, antibioticfree cell culture conditions are necessary. Germfree cell culture working conditions refer to those conditions which reduce the probability of contamination as much as possible, since absolute sterility is not possible. To achieve this, accurate techniques for sterile cell culture work is necessary. FMD is an acute contagious viral disease of cloven footed animals (Orsel et al., 2007) . The causative agent is a single stranded positivesense RNA virus that belongs to the genus Aphthovirus in the family Picornaviridae. There are seven immunologically distinct serotypes of FMD virus, namely; O, A, C,, SAT1, SAT2, SAT3 and Asia1 (Belsham, 1993) .
FMD virion has a symmetric protein shell (or capsid) enclosing the genomic RNA. Genome RNA contains a positive single-strand chain approximately 8.3 kb long and encodes a single long open reading frame (ORF) of about 7 kb with two alternative initiation sites. The ORF is flanked by a long 5ʹ-untranslated region (5ʹ-UTR) and a short 3ʹ-UTR, and ends with a genetic-ally encoded poly(A) tail (Grubman 1980) . A genome-linked viral nonstructural protein (NSP), 3B (also known as VPg) containing 23-24 amino acid (aa) residues, is covalently bound to its 5ʹ end, although this protein is rapidly re-leased into an infected cell and is deemed to play no part in translation initiation (Lin et al., 2009) . The viral ORF can be translated into a polyprotein of about 250 kDa, which is subsequently cleaved by two virus-encoded proteinases (leader (Lpro) and 3Cpro) to yield structural and NSPs (Robertson  et al., 1985 and Mason et al., 2003) .
In Egypt, The history of FMD virus goes back to 1950 (Mousa et al., 1974) , when an outbreak caused by serotype SAT2 was reported. Between 1964 and 2005, only serotype O was reported in Egypt (Zahran 1960, and Farag et  al., 2005) , with the exception of 1972 when type A was introduced from Sub-Saharan Africa (Knowles et al., 2007) . Series of outbreaks predominantly caused by serotype O, and with a dramatic upsurge in FMD SAT 2 outbreaks during 2012 were reported (Ahmed et al., 2012,  Shawkey et al., 2013) . Serotypes O, A and SAT2 have been circulating in the country since 2012, and Serotype O is considered the predominant serotype (FAO 2012).
The objective of this study was to Screen the antiviral activity of some members of aminoglycosides on FMD viruses used in the preparation of polyvalent FMD virus vaccine in VSVRI.
Study of In-Vitro Antiviral Activity of Aminoglycosides on Foot and Mouth Disease Virus
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MATERIALS AND METHODS
BHK Cells
BHK cell line obtained from (FMD department, VSVRI, Egypt) was cultured in Minimal essential medium supplemented with a set of proteins including lactalbumin, treptose phosphate broth were added into this medium, sodium bicarbonate, and 10% newborn calf serum supplied by Capricorn®.
FMD Virus Strains
Local 
Aminogylcoside Antibiotics
Monitoring the inhibitory effect of neomycin (200, 500 mg/L), kanamycin (200, 500 mg/L), gentamycin (200, 500 mg/L) and streptomycin (200, 500 mg/L) on FMD viruses-induced CPE on BHK cells has been screened using the inverted microscope. Positive (aminoglycosidesfree) and negative (FMD viruses-free) were used.
Inverted Microscope
The CPE of FMD viruses on BHK cells was investigated using the inverted microscope.
RESULTS AND DISCUSSION
Aminoglycosides are one of the most important classes of antibiotics used in tissue culture technique that inhibit bacterial protein synthesis by targeting the ribosome (Magnet and Blanchard 2005). They are also excellent templates for antibiotic design because of their high binding affinity and properties that allow for broadspectrum antibacterial activity (Sutcliffe 2005). et al., 1986, 1987, Zapp et al., 1993, Herold  and Spear 1994, Herold et al., 1994, Litovchick  et al., 2000, 2001, Hung et al., 2002 and Smita et al. 2018 who mentioned that the neomycin has mediated a potent antiviral effect.
The effect of aminoglycosides on The 24 hrs-37ºC infectivity titers expressed as TCID50/ml of FMD viruses treated by different concentrations of aminoglycosides antibiotics starting as 10 8 TCID50/ml revealed that all the aminoglycosides in this study affect infectivity titers (expressed as TCID50) except streptomycin (at concentrations ≤ 500 mg/L) as shown in table (2) . 1980,1983, Macintyre et al., 1991a,b, Ghendon  et al., 1981 and Gatti et al., 1998 who mentioned that the neomycin inhibit RND viruses replication and viral entry.
In this work we studied the In-vitro effects of Aminoglycosides antibiotics on FMD viruses used in preparation of polyvalent FMD vaccine in VSVRI in Egypt. The effects concerned in this study we CPE formation on BHK cells and infectivity titers.
The antibacterial mechanism of action of aminoglycosides has been well characterized, and it was discovered in the late 1980s that aminoglycosides molecular target is the 16S rRNA subunit of the 30S bacterial ribosome Our results are also confirmed by Ingrid Kuhlmann (1996) who mentioned that the prophylactic use of antibiotics risks neglect of sterile technique. Moreover, antibiotics may have side effects on the cells. Consequently, the prophylactic use of antibiotics may effect the results of experiments.
Finally we recommend the avoidance of using aminoglycosides antibiotics (except streptomycin at concentration ≤ 500 mg/L) in treating FMD virus suspensions or isolation of FMD viruses as it may weaken or even inhibit these RNA viruses. Also the routine inclusion of aminoglycosides antibiotics in tissue culture technique is contraindicated.
